US HB1450 | 2009-2010 | 111th Congress
Status
Spectrum: Moderate Partisan Bill (Republican 4-1)
Status: Introduced on March 11 2009 - 25% progression, died in committee
Action: 2009-04-27 - Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Pending: House Subcommittee on Crime, Terrorism, and Homeland Security Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on March 11 2009 - 25% progression, died in committee
Action: 2009-04-27 - Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Pending: House Subcommittee on Crime, Terrorism, and Homeland Security Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Counterfeit Drug Prevention Act of 2009 - Amends the Federal Food, Drug, and Cosmetic Act to establish criminal penalties of a fine and imprisonment for not more than 20 years, or both, for any person who commits a prohibited act relating to counterfeiting knowing that: (1) the conduct concerns the rendering of a drug as a counterfeit drug; (2) the conduct will cause a drug to be a counterfeit drug; or (3) a drug, held, sold, or dispensed is a counterfeit drug. Increases the term of imprisonment to any term of years or for life if the use of a counterfeit drug is the proximate cause of a consumer's death. Modifies provisions pertaining to criminal fines for committing certain prohibited acts involving food, drugs, devices, or cosmetics.
Title
Counterfeit Drug Prevention Act of 2009
Sponsors
Rep. Michael Burgess [R-TX] | Rep. Steve Buyer [R-IN] | Rep. Gene Green [D-TX] | Rep. Mike J. Rogers [R-MI] |
Rep. Fred Upton [R-MI] |
History
Date | Chamber | Action |
---|---|---|
2009-04-27 | Referred to the Subcommittee on Crime, Terrorism, and Homeland Security. | |
2009-03-12 | Referred to the Subcommittee on Health. | |
2009-03-11 | Referred to House Judiciary | |
2009-03-11 | Referred to House Energy and Commerce | |
2009-03-11 | Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. |
Subjects
Criminal procedure and sentencing
Drug safety, medical device, and laboratory regulation
Fraud offenses and financial crimes
Health
Drug safety, medical device, and laboratory regulation
Fraud offenses and financial crimes
Health
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/111th-congress/house-bill/1450/all-info |
Text | https://www.congress.gov/111/bills/hr1450/BILLS-111hr1450ih.pdf |